0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Special Feature |  FREE
Arch Pediatr Adolesc Med. 2012;166(4):378-379. doi:10.1001/archpediatrics.2011.875b.

Special Feature |  FREE
Arch Pediatr Adolesc Med. 2008;162(10):990. doi:10.1001/archpedi.162.10.990.

Sign in

Purchase Options

• Subscribe to the journal

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Dermatology
Research Letter  | 
Open-Label Trial of MABp1, a True Human Monoclonal Antibody Targeting Interleukin 1α, for the Treatment of Psoriasis
Kyle M. Coleman, MD; Johann E. Gudjonsson, MD, PhD; Michael Stecher, MD
JAMA Dermatology
Original Investigation  | 
Effect of Psoriasis Severity on Hypertension Control:  A Population-Based Study in the United Kingdom
Junko Takeshita, MD, PhD; Shuwei Wang, MD; Daniel B. Shin, MS; et al.
JAMA Dermatology
Review  | 
Economic Burden of Psoriasis in the United States:  A Systematic Review
Elizabeth A. Brezinski, MD; Jaskaran S. Dhillon; April W. Armstrong, MD, MPH
JAMA Dermatology
Consensus Statement  | 
Treatment of Nail Psoriasis:  Best Practice Recommendations From the Medical Board of the National Psoriasis Foundation
Jeffrey J. Crowley, MD; Jeffrey M. Weinberg, MD; Jashin J. Wu, MD; et al.